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Abstract.  Somatostatin (SRIF) is a  14-amino acid 
peptide hormone that is synthesized as part of a larger 
precursor, preproSRIE  consisting of a  signal peptide 
and a proregion of 80-90 amino acids.  The mature 
hormone,  which is located at the carboxyl terminus of 
the precursor,  is preceded by a  single pair of basic 
amino acids.  We are studying preproSRIF to inves- 
tigate intracellular  sorting, proteolytic processing,  and 
storage of peptide hormone precursors in the secretory 
pathway.  We used a  retroviral expression vector to 
achieve the high levels of precursor synthesis which 
are necessary for detailed characterization  of process- 
ing intermediates and mature somatostatin.  Recom- 
binant retroviruses containing  RNA transcripts  encod- 
ing anglerfish preproSRIF I were used to infect rat 
pituitary GH3 cells which secrete growth hormone and 
prolactin,  neither of which are substrates for en- 
doproteolytic cleavage. In these cells preproSRIF was 
accurately processed to the mature hormone with an 
efficiency of ,x,75 %.  Of the newly synthesized mature 
SRIE 55%  was sorted into the regulated secretory 
pathway and released in response to the secretagogue 
8-Br-cAMP.  The remaining 45 % of mature SRIF and 
residual unprocessed precursor was rapidly secreted. 
In contrast to SRIF, only 5 % of newly synthesized en- 
dogenous growth hormone was stored intracellularly, 
whereas 95% was sorted to the constitutive pathway 
and secreted rapidly with kinetics identical to pro- 
SRIE Our results show that proSRIF processing is not 
necessarily dependent on a  specific protease found 
only in SRIF-producing cells and suggest that proteo- 
lyric cleavage is not restricted to cells that process en- 
dogenous hormones.  Moreover, these results demon- 
strate that GH3 cells have the capacity to discriminate 
between endogenous and foreign hormones and target 
the foreign molecule significantly more efficiently to 
the regulated secretory pathway. 
M 
OST small peptide hormones and neuropeptides are 
synthesized  as part of larger inactive  precursors 
(8) which undergo one or several posttranslational 
modifications including glycosylation, proteolysis, phosphor- 
ylation, amidation,  and acetylation to generate  a bioactive 
molecule (8, 21). These processing events occur in different 
organelles  during  intracellular  transport and therefore pep- 
tide hormone precursors are useful models to study sorting 
through the secretory pathway. Several sorting and process- 
ing events occur in the distal elements  of the Golgi appara- 
tus/trans-Golgi  network and in maturing  secretory granules 
(13, 26-28,  34). In particular,  endoproteolytic cleavage of 
peptide hormone precursors at paired basic residues is initi- 
ated in acidic,  clathrin-coated  vesicles which bud from the 
trans-Golgi network and  the resulting  mature hormone is 
stored in secretory granules (28, 34). At present, the molecu- 
lar signals  that target a polypeptide to the so-called "regu- 
lated" secretory pathway, the products of which are released 
in response to secretagogues,  are poorly understood.  Hot- 
mone-secreting  cells also undergo  basal or "constitutive" 
secretion,  in which unprocessed precursors,  nonhormone 
secretory proteins,  and plasma membrane proteins  are con- 
tinuously  delivered to the cell surface (3, 17); the evidence 
suggests that entry into the constitutive  pathway occurs by 
default (17, 30). Consequently, a mechanism must exist which 
enables cells to discriminate between molecules destined for 
the regulated  or constitutive  pathways (17). 
Our laboratory has been investigating  the expression of 
peptide hormone precursors in foreign cells (12, 36) to (a) 
determine which secretory cells have prohormone cleavage 
enzymes and (b) identify structural  domains within precur- 
sors which might function in targeting to the regulated secre- 
tory pathway. To address these questions, we are studying the 
biosynthesis and processing of prosomatostatin  (proSRIF) as 
a model for intracellular  sorting  and prohormone process- 
1. Abbreviations  used in this paper: GH, growth hormone; SRIE somato- 
statin. 
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is  synthesized as part of a  larger precursor,  preproSRIE 
PreproSRIF is one of the simplest precursors (16, 35,  36) 
consisting of a 20-25-amino acid signal peptide followed by 
a proregion of 80-90 residues. The mature hormone is lo- 
cated at the carboxyl terminus of the propeptide and is pre- 
ceded by a single pair of basic amino acids: ArgLys. Apart 
from endoproteolytic cleavage,  the precursor undergoes no 
other posttranslational modifications (25). 
Several  investigators using gene transfer techniques have 
introduced foreign precursors into pituitary AtT-20 cells or 
pancreatic islet RIN cells, e.g., preproenkephalin (6,  33), 
preproinsulin (24),  pretrypsinogen (4),  preproSRIF  (32), 
preprorenin (10), and preproneuropeptide Y (7). These pre- 
cursors were proteolytically cleaved to the mature hormone 
and in some cases targeted to the regulated pathway, albeit 
with variable efficiency. In contrast, viral membrane glyco- 
proteins and laminin were constitutively released (4, 11, 17). 
Expression of peptide hormone precursors  in fibroblasts, 
which manifest only the constitutive pathway, results in little 
(36) or no proteolytic processing (15, 32, 33) with the con- 
comitant secretion of unprocessed precursors. These obser- 
vations imply that only ceils which normally process their 
endogenous precursors have proteases capable of cleaving 
precursors to the mature hormone. However, for some cells 
such as the rat somatotroph line GH4C1 (which synthesizes 
growth hormone and prolactin) the data are contradictory. 
Hellerman et al.  demonstrated correct processing of pro- 
parathyroid hormone (15) to the mature hormone, whereas 
neither proenkephalin (33) nor proSRIF (32) were processed 
in these cells or in a rat pheochromocytoma  line, PC-12 (32). 
To determine if endocrine cells which synthesize poly- 
peptide hormones that are not cleaved have prohormone- 
converting enzymes, we exploited the rat anterior pituitary 
line GH3 (2).  Our choice was predicated on several  obser- 
vations: (a) GH3 cells synthesize high levels of growth hor- 
mone and prolactin, both of which contain several  sets of 
paired basic amino acids, however these hormones are not 
substrates for endoproteolytic processing; (b) synthesis and 
secretion of the endogenous hormones can be modulated by 
other hormones and ligands such as glucocorticoids, thy- 
rotropin releasing hormone, and forskolin; and (c) most im- 
portantly previous studies from this laboratory (11) demon- 
strated  that  GH3  cells  efficiently discriminate  in  sorting 
between membrane glycoproteins and endogenous growth 
hormone, probably in the distal elements of the Golgi ap- 
paratus. 
In earlier studies (36), low levels of  prohormone synthesis, 
resulting from transient gene expression, precluded detailed 
characterization and  analysis of processing  intermediates 
and the mature peptides.  To circumvent this problem,  we 
used a recombinant retrovirus expression vector pLJ (18), 
which contains the highly efficient murine leukemia virus 
promoter and a selectable marker, to generate clonal lines of 
GH3 cells expressing high levels  of preproSRIE  Here we 
show that GH3 cells accurately and efficiently process pro- 
SRIF to the mature hormone. Approximately 75 % of the in- 
tracellular precursor is processed to mature SRIF and at least 
half of this material is targeted to the regulated pathway. In 
contrast, 95 % of newly synthesized endogenous growth hor- 
mone was delivered to the constitutive pathway. We conclude 
that GH3 cells discriminate between and store a foreign pro- 
tein more efficiently than an endogenous hormone. 
Materials and Methods 
Materials 
Psi-2 cells (22) and the plasmid pLJ were a gift from Dr. Richard Mulligan, 
The Whitehead Institute, Boston, MA. Rabbit anti-SRIF serum, designated 
RSS-1, was prepared in this laboratory as previously described (35). Baboon 
anti-growth hormone serum was a generous gift from Dr. Carter Bancroft, 
Mount Sinai Medical Center, NY. [3SS]Methionine and [3sS]cysteine were 
purchased at the highest available specific activity from Amersham Corp., 
Arlington Heights, IL. 
Methods 
Cell Culture. Cells were grown at 37°C in an atmosphere of 7.5%  CO:. 
GH3 cells were grown in Ham's F10 medium (3 g/ml NaHCO3)  supple- 
mented with 15% equine serum, 2.5% FBS, 2 mM glutamine, 25 U/ml pen- 
icillin, and 25 I~g/ml streptomycin. NIH 3T3 and Psi-2 cells were grown 
in DME supplemented with 10% FBS, 2 mM glutamine, 25 U/ml penicil- 
lin, and 25  ~tg/ml streptomycin. 
Production of Recombinant Retrovirus Expressing preproSRIE  A 
462-bp eDNA fragment encoding preproSRIF was ligated into the Barn HI 
site of the retroviral expression vector, pLJ (see Fig.  1), and the resulting 
plasmid DNAs amplified in Escherichia coli strain C600 grown in the pres- 
ence of  40 gg/ml of  kanamycin. Infectious virus particles containing prepro- 
SRIF RNA transcripts were generated by transfecting Psi-2 cells (22) with 
plasmid DNA according to the Polybrene-DMSO method (5). 48 h after the 
DMSO treatment, l  mg/ml of the neomycin analogue (3418 was added to 
the culture medium. The medium containing G418 was changed after 5 d 
and after a total of 10 d  growth in G418,  resistant cells (100-1,000  colo- 
nies/dish) were trypsinized and recultured until 80% confluent. Virus tiler 
ranged from 103 to 105 infectious U/ml. 
Infection of  Target GH3 Cells. Medium from semi-confluent  G418 resis- 
tant Psi-2 cells was filtered through a 0.45-I.tm filter. A 60-ram dish contain- 
ing 106 GH3 cells was incubated for 2 h with 1 ml of the filtered Psi-2 cell 
medium containing 10 gg of polybrene. 4 ml of complete Ham's F10 was 
added and the medium changed after 24 h. 48-h postinfection, the medium 
was replaced with 5 ml of complete F10 containing 1 mg/m113418. This was 
changed after 5 d with fresh medium containing 13418. 10-d postinfection, 
G418-resistant cells were trypsinized, reseeded, and grown to 80% conflu- 
ency. Single G418-resistant cells were subcultured by limiting dilution in a 
96-weU plate and 10-20 clonal lines were grown to mass culture. The steady 
state levels of intracellular and secreted SRIF was determined by radio- 
immunoassay. 
Biosynthetic Labeling of Cells. 60-mm dishes were seeded with 2  x 
106 cells, 48-96 h later the cells were washed twice with 2 ml of PBS and 
pulse labeled for the indicated times with I ml of labeling medium supple- 
mented with 2 mM glutamine, 250 gCi/ml of [35S]cysteine or [3~S]methio- 
nine in the absence or presence of  2.5 % beat-inactivated FBS and heat-inac- 
tivated equine serum. Labeling medium was prepared from a RPMI-1640 
SelectAmine Kit (Gibco Laboratories,  Grand Island,  NY)  according to 
manufacturer's instructions. Cysteine or methionine was omitted from label- 
ing medium containing [35S]cysteine or [35S]methionine,  respectively. For 
the chase incubations, cells were washed twice with 2 mi of PBS and 1 ml 
of chase medium containing complete Ham's FIO (containing a full comple- 
ment of unlabeled amino acids) was added. In some experiments, the chase 
medium contained 10 ~tl/ml of specified antiserum. 
After the labeling and chase periods, the medium was removed, cen- 
trifuged for 10 s in a microcentrifuge (model 5412;  Brinkman Instruments 
Co., Westhury,  NY), transferred to a fresh tube, and stored on ice or at 
-20°C until treated with antiserum. Cells were washed with PBS, and har- 
vested by scraping with a rubber policeman into 1 mi of PBS. The cell sus- 
pension was centrifuged for lO s in a microcentrifuge, the pellet of cells was 
lysed by vortexing, 10 times 1 s each, in 100 ltl of lysis buffer (0.5 % NP-40, 
0.5% Na desoxycholate in PBS) containing a cocktail of protease inhibitors 
(11). Membranes and nuclei were removed by centrifugation at 4oc for 
5 min in a microcentrifuge. The postnuclear supernatants were stored on 
ice or at  -20°C until treated with antiserum. 
lmraunopreeipitation. To determine the intracellular levels of SRIF- and 
growth hormone-related products, postnuclear supernatants were adjusted 
to 1% SDS and incubated at room temperature for 10 min. 10 vol of buffer 
A (190 mM NaC1,  50 mM Tris-HCl pH 8.3, 6 mM EDTA, 2.5%  Triton 
X-100,  100 U/ml trasylol, 5 mM cysteine or methionine) were added fol- 
lowed by addition of 10  gl of appropriate antiserum.  Samples were in- 
cubated at 40C for 12-24 h with constant mixing. To assay for secre~d poly- 
peptides,  medium  was  adjusted  to  buffer A  conditions by  addition of 
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of appropriate  antiserum (if not added to the labeling or chase medium). 
Samples  were incubated with constant mixing at 4°C for 12-24 h. 
Samples were then incubated with 75 ~tl of a 1:3 (vol/vol) slurry of protein 
A-Sepharose at 4°C for 3 h. Immune complexes  were isolated by centrifu- 
gation, washed twice with 750 pl of buffer B (150 mM NaCI,  10 mM Tris- 
HCI pH 8.3, 5 mM EDTA, 0.1% Triton X-100, 100 U/ml tmsylol, 5 mM 
cysteine or methionine, l mg/ml BSA), twice with 750 I.tl of PBS, and used 
immediately  or stored at -20°C until analyzed by HPLC or SDS-PAGE. 
For consecutive immunoprecipitations,  5 I11 of the second antiserum was 
added to the postnuclear supernatants and medium after removal of the ini- 
tial immune complexes. 
It should be noted that the recovery of immuuoreactive proSRIF and ma- 
ture SRIF from cell lysates was less efficient than from the medium. Where- 
as 80% of the total pulse-labeled mature SRIF and proSRIF was recovered 
from the medium, 60% of mature SRIF and 40% of proSRIF, respectively, 
were recovered from the cell lysates. This was determined by three sequen- 
tial precipitations  with anti-SRIF antisera; these numbers were used in 
generating the data for Fig.  6. 
Characterization of  Expressed Proteins. To analyze SRIF-immunoreac- 
tire polypeptides,  HPLC methods were  used.  The protein A-Sepharose 
beads from the immunoprecipitation step (above) were incubated for 30 min 
at 50°C with 50 p.l of TEU buffer (8 M Urea, 500 mM Tris pH 8.8, 20 mM 
EDTA), containing 100 mM dithiothreitol and 2 p.g of native SRIF (as an 
internal standard to monitor retention time). 50 pl of  0.66 M iodoacetie acid 
in TEU was added to the beads and incubated in the dark at room tempera- 
ture for 10 rain, samples were centrifuged, and the supernatant saved. The 
pellet was washed twice with 50 p,1 of TEU, all supernatants were combined 
and 20 p,l of 80% CH3CN,  1% trifluoracetic acid (TFA) added.  Samples 
were analyzed using an HPLC system (model 6000A solvent delivery sys- 
tem; Waters Instruments, Inc., Milford, MA) as previously described (35). 
The combined supernatants  were resolved  on a Vydac C,s reverse  phase 
column (The Separations Group, Hesperia, CA) using one of following gra- 
dient systems.  Gradient 1:0-10 min 25%  CH3CN,  10-35 min 25-50% 
CH~CN. Gradient 2:0-5 min 5% CH~CN, 5-6 rain 5-30% CH3CN, 6-21 
rain  30-45%  CH3CN,  21-25  rain  45%  CH3CN,  25-26  rain  45-80% 
CH3CN, 26-35 min 80% CH3CN. All solutions contained 0.1% TFA. The 
flow rate was 1.5 ml/min and 1-minute fractions were collected and the ra- 
dioactivity determined using a liquid scintillation counter (model LS-8100; 
Beckman Instruments, Inc., Palo Alto, CA). 70-90% of the applied radio- 
activity was recovered  from the column. 
Automated Microsequencing. Automated Edman degradation was per- 
formed using a Beckman 890C Spinning Cup sequencer (Beckman Instru- 
ments, Inc.) as previously described (35).  Repetitive yields were routinely 
92-93% and the chemical yields were 20-25%. 
Results 
Characterization  of GH3S18 Clonal Lines 
To  obtain a  high level  of preproSRIF  expression in GH3 
cells, we used the retroviral expression vector pLJ. Plasmid 
pLJ contains the Moloney murine leukemia virus provirus. 
The 5' long terminal repeat (LTR) in the provirus drives tran- 
scription of inserted sequences and the SV-40 early promoter 
in the ORI region drives expression of the neomycin-resis- 
tance gene for selection on G418. A 462-bp Barn HI cDNA 
fragment encoding anglerfish preproSRIF I was ligated into 
the Bam HI site in pLJ, this plasmid was designated pLJS18 
(Fig.  1).  Psi-2  cells  were  transfected with pLJS18  DNA 
and recombinant retrovirus was obtained (see Materials and 
Methods); this was used to infect the target GH3 cells.  15 
G418-resistant GH3 clonal lines were selected and the me- 
dia and cell lysates assayed for SRIF-immunoreactive mate- 
rial using a radioimmunoassay which showed that the level 
of SRIF varied over a fourfold range (data not shown). 
Identity of  Expressed Products 
To characterize the SRIF-immunoreactive material in these 
cells, four GH3S18 clonal lines and four lines of identically 
infected XG10  cells (clonal variants of GH3 cells,  kindly 
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Figure L  Construction of pLJS18: a  retroviral vector encoding 
preproSRIE A 462-bp Barn HI cDNA fragment encoding angler- 
fish preproSRIF I was excised from either plasmid pLaSh (16) or 
pSVppS18 (36), and ligated into the unique Barn HI site of pLJ; the 
resulting plasmid was designated pI_JS18.  The transcription initia- 
tion and termination sites for DNA ligated into this site are con- 
rained in the murine leukemia virus (MLV) long terminal repeats 
(LTR). Expression of the neomycin gene for resistance to G418 is 
initiated from the SV-40 early promoter in the Ori region. The orga- 
nization of preproSRIF polypeptide is shown; the site of signal pep- 
tide cleavage between Cys(C) and Ser(S) (arrow) and the position 
of the only set of paired-basic residues ArgLys (RK) are indicated. 
The arrowhead indicates the start of mature SRIF-14, located at the 
carboxyl terminus of the molecule (shaded area). 
provided by Dr. R. Vandlen, Genentech Inc., San Francisco, 
CA) were pulse labeled for 90 min with [35S]cysteine. There 
are two cysteine residues in proSRIF I which are retained in 
the mature hormone, i.e., residues 3 and t4, respectively. 
After labeling, the cells were lysed and treated with anti- 
SRIF antiserum and the SRIF-immunoprecipitated polypep- 
tides were resolved by SDS-PAGE (Fig. 2). A specific SRIF- 
related polypeptide of Mr  17,000 (Fig.  2,  upper asterisk) 
which comigrated with in vitro synthesized proSRIF (lane 2, 
arrow) was present in the lysates from all infected GH3 and 
XG10 cells (lanes 4-7 and 9-12, respectively); this polypep- 
tide was absent from uninfected cells (lanes 3 and 8). These 
results indicated that all the GH3 and XG10 clones express 
preproSRIF cDNA and cleave the nascent precursor to pro- 
SRIE In addition, they synthesized variable levels of a low 
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lines. Four GH3S18 and XGIOSI8 clonal lines were pulse labeled 
for 90 rain with  [35S]cysteine  and the SRIF-immunopreeipitated 
polypeptides resolved upon 18% polyacrylamide SDS gels. Lanes 
1 and 2,  in vitro translation products of anglerfish islet mRNA 
translated in the absence (lane 1) or presence of microsomal mem- 
branes (lane 2). After incubation, the translation products were im- 
munoprecipitated with anti-SRIF serum. Lane 1, upper and lower 
bands correspond to preproSRIF I (Mr 18,000) and preproSRIF II 
(Mr 16,000) (35); Lane 2, the arrowhead indicates the mobility of 
proSRIF I (Mr 17,000), the lower band corresponds to proSRIF II. 
Lanes 3 and 8, SRIF-immunoprecipitable products from uninfected 
GH3SI8 and XG10SI8 cells, respectively. Lanes 4-7, SRIF-immu- 
noreactive material from GH3S18 clones 2,  5, 8, and 9, respec- 
tively. Lanes 9-12, SRIF-immunoreactive material from XG10S18 
clones 3, 4, 5, and 7, respectively. The single asterisk indicates the 
position of proSRIF I (Mr 17,000) present in lysates from all in- 
fected cell lines. Note that this polypeptide comigrates with pro- 
SRIF I synthesized in vitro in the presence of microsomal mem- 
branes  (lane 2).  The double asterisk  indicates the migration of 
mature SRIE 
molecular mass SRIF-immunoreactive polypeptide that was 
poorly resolved by SDS-PAGE (Fig. 2, double asterisks). We 
suspected that this material corresponded to mature SRIE 
which was not well resolved by SDS-PAGE because of its 
small size (14 amino acids). 
To identify this material, SRIF-immunoprecipitated prod- 
ucts from GH3S18.9  cell lysates were analyzed by HPLC 
using a Cjs reverse-phase column (Fig. 3 A). Two peaks of 
SRIF-immunoreactive material,  retention times  14 and 29 
rain, respectively, were resolved. The first peak exactly co- 
eluted  with  native  reduced  and  carboxymethylated SRIF 
suggesting it was the mature 14-amino acid hormone. The 
second peak, retention time of 29 min, was identified as pro- 
SRIF since it comigrated with in vitro synthesized proSRIF 
upon SDS-PAGE (data not shown). The specificity of these 
peaks was demonstrated by analyzing an equivalent cell ly- 
sate immunoprecipitated in the presence of nonradioactive 
native SRIF (Fig. 3 A, open boxes). To prove that the mate- 
rial eluring at 14 min was mature SRIF, it was subjected to 
microsequencing (Fig. 3 B). The amino acid sequence of na- 
tive SRIF has cysteine residues in positions three and four- 
teen, therefore [35S]eysteine radioactivity should be recov- 
ered in cycles 3 and 14.  The data showed that this was the 
case and  demonstrated  that  GH3  cells  accurately cleaved 
proSRIF to the mature peptide. 
Kinetics and E~ciency of  Processing and Secretion 
GH3S18.9 cells were pulse labeled with [35S]cysteine for 15 
min and chased for up to 6 h. At each time point, intracel- 
lular and secreted SRIF-immunoreactive products were re- 
solved by HPLC (Fig. 4). With increasing duration of chase, 
the level of intracellular proSRIF decreased with a concomi- 
tant increase in mature SRIE After '~30 min of chase, ma- 
ture SRIF appeared in the medium and reached a maximum 
between 90 and 120 min. Since GH is endogenously synthe- 
sized and secreted in these cells, samples from the same ex- 
periment were treated with anti-GH antiserum, after treat- 
ment  with  SRIF  antiserum,  and  the  immune  complexes 
resolved by SDS-PAGE (Fig. 5). The total radioactivity pres- 
ent in proSRIF and mature SRIF was calculated and the ra- 
dioactivity in the intracellular and secreted GH polypeptides 
determined  by  liquid  scintillation  counting.  The  relative 
efficiency of processing and the secretion kinetics of these 
molecules was then determined (Fig. 6). As previously ob- 
served (2,  11, 31), intracellular GH disappeared rapidly, t,~ 
~,,20 min, from the ceils and was secreted into the medium 
(Fig. 6, A and B). Virtually all of the initially pulse-labeled 
GH could be accounted for in the subsequent chase periods. 
After a 360-min chase, only 5 % of the GH was intraceUular 
whereas 95%  was  recovered in the medium.  Intracellular 
proSRIF disappeared with a half-life of ,x/20 rain, ,x,25 % of 
the initially synthesized proSRIF was secreted (unprocessed) 
with  kinetics  almost identical to GH  (Fig.  6  D).  All but 
5-10%  of the  residual  proSRIF  was  proteolytically pro- 
cessed to mature SRIF, of which 45 % was also secreted con- 
stitutively with kinetics similar to GH. Most significantly, 
and in contrast to GH, the remaining 55 % of mature SRIF 
was stored intracellularly with a half-life >6 h  (Fig. 6  C). 
Characterization of  the Intracellular Pool 
of  SRIF and GH 
We hypothesized that the intracellular pool of stored SRIF 
was targeted to the regulated secretory pathway. If this were 
correct, it should be released upon stimulation by secreta- 
gogues (17). Cells were pulse labeled with [35S]cysteine for 
15 min and chased for 120 min. After this initial chase, the 
medium was removed and replaced with fresh medium or 
medium  containing  5  mM  8-Br-cAMP  and  the  cells  in- 
cubated for an additional  120 min. The cells and medium 
from each time point were then treated with anti-SRIF an- 
tiserum and the products analyzed by HPLC (Fig.  7).  A 
similar experiment was performed to characterize the intra- 
cellular GH pool; GH3S18.9  cells were pulse labeled with 
[35S]cysteine for 15 min and chased for 90 min; the medium 
was  removed and  replaced  with  either  medium  alone or 
medium  containing  5  mM  8-Br-cAMP  and  the  cells  in- 
cubated for an additional 60 min.  The cells and medium 
from each time point were treated with anti-GH antiserum 
and the products analyzed by SDS-PAGE (Fig.  7).  During 
the second  120-rain chase period in the absence of 8-Br- 
cAMP, ~15% of the stored mature SRIF was secreted. How- 
ever, in the presence of 8-Br-cAMP,  88%  of SRIF-14 was 
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Figure 3.  Characterization of in- 
tracellular SRIF-immunoreactive 
material from GH3S18 cell lines. 
(A)  HPLC  analysis.  Cells were 
pulse  labeled with  [35S]cysteine 
for 90 min and the lysate treated 
with anti-SRIF antisera in the ab- 
sence (solid circles)  or presence 
of  10  gg  nonradioactive  SRIF 
(open boxes),  followed by treat- 
ment with protein A-Sepharose. 
The immune complexes were dis- 
sociated using a urea buffer (Ma- 
terials  and Methods) and resolved 
on  a  Vydac  Cta  reverse  phase 
HPLC  column  using  gradient 
system  I  (Materials  and  Meth- 
ods).  The  radioactivity in  each 
fraction was determined by liquid 
scintillation counting. The arrow 
indicates the elution position of 
native reduced and carboxymeth- 
ylated  SRIF-14  (retention  time 
14 rain). (B) Partial NH2-termi- 
nal  sequencing.  [35S]Cysteine- 
labeled material coeluting from 
the  HPLC  column  with mature 
SRIF in A was applied directly to 
a  spinning  cup  sequencer  and 
subjected to  19  cycles of auto- 
mated  Edman  degradation  and 
the  radioactivity in  each  cycle 
determined. 
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Figure  4.  HPLC  analysis of 
intraceUular and secreted SRIF- 
immunoreactive material from 
GH3S18.9  cells.  Cells  were 
pulse-labeled (P)  with  [35S]- 
cysteine for  15  min (P)  and 
chased  (C)  for the  indicated 
times. At each time point the 
cells were lysed and the medi- 
um  collected; the  cell lysate 
and medium were treated with 
anti-SRIF antiserum and the 
SRIF-immunoreactive  mate- 
rial  was  resolved by  HPLC 
using gradient system 2 (Ma- 
terials and Methods). The ra- 
dioactivity  in  each  fraction 
was determined by liquid scin- 
tillation counting; (Top)  Cell 
lysate; (bottom) secreted ma- 
terial.  The  CH3CN  gradient 
is  shown  in  the  upper  right 
panel.  Arrowheads  indicate 
the elntion position of mature 
SRIF  and  proSRIF,  respec- 
tively. 
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ples were obtained from the pulse-chase experiment shown in Fig. 
4. After treatment with SRIF antiserum and protein A-Sepharose, 
the supernatants were incubated with 5 txl anti-GH antiserum and 
the immunoprecipitable material resolved by SDS-PAGE. An auto- 
radiogram of the gel is shown. The kinetics of GH secretion were 
identical in uninfected GH3 cells (not shown). Lanes 1-6, intracel- 
lular GH; lanes  7-12, secreted GH. P  indicates the  15-min pulse 
and C corresponds  to the indicated chase times. 
secreted  into  the  medium.  The  near  complete  release of 
stored SRIF by the secretagogue, 8-Br-cAMP, demonstrated 
that these molecules were targeted to the regulated pathway. 
Although secretion of the residual GH was similarly stimu- 
lated by 8-Br-cAMP (Fig.  7),  it should  be noted that this 
represents only 5-10% of the initially synthesized GH pool. 
In contrast, the corresponding SRIF pool was 55 % of total 
mature hormone. These results demonstrated not only that 
GH3 cells have a regulated secretory pathway but that they 
also possess an efficient mechanism for selectively sorting 
SRIF from GH. 
Discussion 
We have previously described (36) the expression of prepro- 
SRIF in monkey kidney cells (COS 7) and demonstrated cor- 
rect,  although  inefficient,  cleavage of proSRIF and corre- 
spondingly low levels of mature hormone secretion. Similarly, 
Sevarino et al.  (32)  recently showed that rat proSRIF was 
also inefficiently processed in 3T3 cells. In agreement with 
these reports, we observed no proSRIF cleavage in 3T3 cells 
(data not shown). Analysis of processing efficiency, storage, 
and secretion requires gene expression at levels sufficiently 
high to facilitate detailed biochemical characterization of the 
unprocessed and  mature molecules.  To this  end,  we have 
used a  recombinant retroviral expression vector, pLJ (18), 
which allows cDNA integration into the host cell genome; 
transcription of the cDNA is driven by the highly active pro- 
moter  within  the  Moloney  murine  leukemia  virus  LTR. 
Using this system, we expressed preproSRIF in GH3 cells 
at levels approaching those of the endogenous growth hor- 
mone as determined by radioimmunoassay (Fleischer,  N., 
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Figure 6  Comparison  of the processing and se- 
cretion  kinetics  of pmSRIE  SRIE  and  GH  in 
GH3S18.9 cells. The bands, corresponding to GH- 
specific polypeptides from a similar experiment to 
that shown in Fig. 5, were excised and the radioac- 
tivity in the solubilized gel pieces determined. (A) 
Radioactivity in intracellular GH; (B) radioactiv- 
ity in secreted GH. Cells were pulse labeled with 
[35S]cysteine for 15 rain and chased for up to 360 
min; at each time point the cell lysate and medium 
were treated with  anti-SRIF antiserum,  the  im- 
munoreactive material resolved by HPLC, and the 
radioactivity in the appropriate peaks determined. 
(C)  Radioactivity  in  intracellular  mature  SRIF 
(solid circles) and proSRIF (open circles). (D) Ra- 
dioactivity in secreted mature SRIF (solid circles) 
and  proSRIF  (open  circles). Note that the  data 
were  corrected  for differential  recovery  of pro- 
SRIF and mature SRIF (Materials and Methods). 
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Figure 7. Secretagogue-mediated  secretion of intraceUular  SRIF and 
GH. GH~S18.9 cells were pulse labeled for 15 min with [3~S]cys- 
teine and chased for 120 (SRIF) or 90 min (GH). The medium was 
removed and the cells incubated for an additional 120 (SRIF) or 60 
rain (GH) in the absence or presence of 5 mM 8-Br-cAMP. The 
cells and medium from each time point were treated with anti-SRIF 
antisera or with anti-GH antiserum. The immunoprecipitates  were 
analyzed by HPLC (SRIF-immunoreactive  polypeptides) or SDS- 
PAGE (GH-related products). The total radioactivity in the SRIF- 
related peptides was determined by integration of the appropriate 
HPLC peaks (Fig. 4) and radioactivity in GH polypeptides deter- 
mined by liquid scintillation counting (Fig. 5). Bars represent the 
percent of intracellular material secreted into the medium in the ab- 
sence (crosshatched bars) or presence of 8-Br-cAMP (solid bars); 
the results are averaged from five  experiments. 100%, which corre- 
sponds to the level  of intracellular material before 8-Br-cAMP treat- 
ment was: 3,000 cpm (SRIF-14), 300 cpm (proSRIF), and 450 cpm 
(GH). 
T. Stoller, H. Liker, and D. Shields, manuscript in prepara- 
tion) and established clonal lines synthesizing different levels 
of the precursor.  Our data show that GH3 cells efficiently 
(75 %) and accurately proteolytically  process proSRIF exclu- 
sively to mature SRIF-14. Using a variety of different HPLC 
elution conditions (e.g., in which SRIF-14 elutes 3 min later 
than SRIF-28) there was no evidence of processing to SRIF- 
28,  an  NH2-terminally  extended  form  of  the  hormone. 
Thus, efficient proteolytic cleavage is not restricted to cells 
that process their endogenous hormones nor dependent on 
a specific protease found only in SRIF-producing cells. It is 
noteworthy that proSRIF processing was not related to the 
efficiency of intracellular storage,  since  ~45%  of mature 
SRIF was secreted constitutively. This observation supports 
the hypothesis that processing per se does not mediate target- 
ing to the regulated pathway (17). 
It has  been  reported  that only certain  endocrine  cells 
cleave polyprotein precursors efficiently (6, 9, 24, 32).  Sur- 
prisingly, rat proSRIF, which was processed in RIN 5F cells 
(islet)  and  AtT-20  cells  (pituitary),  was  not  cleaved  in 
GI-LC~ (pituitary) or PC-12  (adrenal  medulla) cells (32); 
this was unexpected for several reasons. Firstly, Hellerman 
et al. (15) showed that proPTH (proparathyroid hormone) is 
accurately cleaved to PTH (at LysLysArg) in GH4C~ cells. 
Secondly, GH4C1 cells are clonal derivatives of the rat GH3 
line, which we demonstrate here cleaves proSRIF accurately 
and efficiently. Thirdly, Low et al. (19) showed in transgenic 
mice containing the rat preproSRIF gene, that proSRIF was 
expressed and processed to mature SRIF in pituitary gonado- 
trophs, thus demonstrating that cells which do not normally 
synthesize proSRIF can process  at paired basic residues. 
Furthermore, since AtT-20 cells cleave several different het- 
erologous prohormones (17),  it seems quite unlikely that 
cell-specific enzymes are required for processing. Our re- 
sults thus contrast with those of Sevarino et al. (32) who sug- 
gested that proSRIF processing requires specific pathways 
present in only some neuroendocrine cells. The reasons for 
this discrepancy are unclear, but could be related to poor 
recovery of mature SRIE Somatostatin is susceptible to non- 
specific proteolysis and it is possible that some cells secrete 
high levels of proteases, leading to low recoveries of the ma- 
ture hormone. Alternatively, GI-LC~ cells might lack or not 
express the gene encoding the processing enzyme; we are 
currently investigating this possibility. 
The efficient processing of proSRIF in GH3 cells was par- 
ticularly intriguing since this precursor has an atypical cleav- 
age site, ArgLys. This combination of paired basic residues 
(on the NH2-terminal side of the hormone) is found in <10% 
ofprohormones. Nevertheless, cleavage at the lysine residue 
was specific and no evidence for miscleavage or for cleavage 
at the preceding arginine was observed. Our data shows that 
cleavage specificity is not determined exclusively by the na- 
ture of the basic amino acids present at the processing site 
and implies that the conformation of this region may be im- 
portant for defining specificity. 
Endocrine cells respond to secretagogues by rapidly re- 
leasing stored hormone; storage requires efficient sorting to 
the regulated secretory pathway. Our results show that 55 % 
of newly synthesized mature SRIF was sorted into the regu- 
lated pathway and virtually all this material was secretagogue 
sensitive. The efficient  storage of SRIF is somewhat unusual, 
since for example, pulse labeling of AtT-20 cells expressing 
GH results in only •10  % of  the newly synthesized GH enter- 
ing the regulated pathway. However since the half-life of ma- 
terial in the regulated pathway is *10 times greater than in 
the constitutive pathway, the fraction of unlabeled hormone 
in storage granules is ,,o80% (Kelly, R., personal communi- 
cation). In contrast to SRIE only 5 % of newly synthesized 
GH was stored in regulated vesicles.  It might be argued that 
since ~25 % of pulse-labeled mature SRIF remained in the 
cells after 6 h of chase that 25 % of radiolabeled GH was also 
present but was not extracted.  However,  this was not the 
case,  since comparison of several  other extraction condi- 
tions, including the use of alkaline and acidic buffers, did 
not enhance total GH recovery (Fleischer, N., T. J. Stoller, 
H. Liker, and D. Shields, manuscript in preparation). Our 
results thus suggest that SRIF is stored significantly more 
efficiently than GH. The constitutive secretion of GH, yet 
storage of the foreign peptide SRIE was unexpected since al- 
though GH secretion is  highly regulated in  situ,  in GH3 
cells it is rapidly secreted (1, 11, 31). A possible explanation 
is that GH produced by GH3 cells has mutated and lacks a 
functional "sorting signal  y Although we cannot exclude this 
possibility, it is unlikely since GH synthesized by these cells 
was recognized by anti-GH antiserum, has the same molecu- 
lar weight, isoelectric point, amino-terminal sequence, and 
biological activity as authentic rat GH (2). 
Stoller  and Shields Retrovi~..s-mediated SRIF Expression  2093 An alternative hypothesis is that our tissue culture medium 
lacks or is rate limiting for a component which is required 
for GH packaging  and storage,  but not for SRIF. In this con- 
text, Scammell et al. (31) showed that treating GI-hC,  cells 
with  a  combination  of estradiol,  insulin,  and  epidermal 
growth factor increased the number and size of mature gran- 
ules, resulting in a fivefold enhancement of stored endogen- 
ously synthesized prolactin. A characteristic  feature of ma- 
ture  secretory  granules  is  an  electron opaque  content  or 
"dense core" composed of highly concentrated semi-crystal- 
line  secretory  product  (29).  Thus,  it  is  possible  that  the 
medium used for growing GH3 cells may be deficient in one 
or more factors necessary  for the concentration of growth 
hormone. 
A third explanation for the differential storage of SRIF and 
GH is that acidification of the trans-Golgi network or secre- 
tory vesicles could be defective in GH3 cells. SRIF packag- 
ing may be less dependent upon a low pH sorting step for 
transport into mature granules than other hormones such as 
growth hormone (14).  The observation (1) that in pancreatic 
islets, SRIF-secretory granules were less acidic than those 
containing insulin or glucagon is consistent with this hypoth- 
esis. However, a direct role for acidification in the process- 
ing, sorting, and packaging of peptide hormones into secre- 
tory granules is somewhat controversial.  Moore et al.  (23) 
showed that treatment  of AtT-20 cells with high concentra- 
tions of chloroquine, which neutralizes acidic intracellular 
compartments,  inhibited  proACTH/endorphin  proteolytic 
processing  and  diverted the precursors to the constitutive 
pathway. In contrast,  Mains and May (20) recently demon- 
strated that low doses of chloroquine, which abolished intra- 
cellular pH gradients,  had no effect on proACTH/endorphin 
processing,  or on secretagogue-stimulated  secretion of the 
mature peptides. Whatever  the mechanism for the differen- 
tial sorting of SRIF and GH, the data presented here demon- 
strate that GH3 cells and their clonal variants  should pro- 
vide important  insights into targeting  proteins to secretory 
granules. 
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